EXPERIENCE brings efficiencies to your clinical development
When you work with Medpace, you benefit from over 20 years of therapeutic excellence in Phase I-IV global clinical research.
Sponsors developing drugs and medical devices that match Medpace's core therapeutic and specialty areas
will find exceptional depth of resources and experience.
Global Phase I-IV Experience
Medpace has the global reach
and resources to conduct studies in drugs,
biologics and medical devices. Our in-house experts work collaboratively to support your entire product
development lifecycle. We provide a full range of services
to advance your compounds and medical devices from early
clinical development through late phase studies.
- Phase I/IIa: Medpace can help assess safety, identify risks, and set a course for successful development at this critical early stage.
- Phase II-III: Medpace provides scientific leadership with disciplined execution,
global access to patients, and local and global regulatory expertise
- Phase IIIb-IV: Extending our integrated model and expert teams into late phase, Medpace conducts both interventional
and non-interventional type studies to address safety and efficacy, outcome decisions, risk management, and post-marketing commitments
Drug - Device Combination Experience
Drug-device combination products can present unique considerations and risks.
With a dedicated Medical Device division
Medpace brings together its medical and regulatory experts into a collaborative team that understands the
nuances from both the drug and device perspectives. Medpace is experienced in helping clients meet regulatory compliance
and ensuring patient safety while accelerating their combination product to market.
Discover the Power of X in Clinical Research
and how Medpace can accelerate your drug and device development with our powerful combination of: